News

doctor notes
AI course-of-care notes help doctors, pose little risk of harm to patients

Agentic large-language models can draft hospital discharge summaries that are safe, useful and demonstrably effective at helping to curb physician burnout, according to research conducted at Stanford University.

Subhasis Chatterjee, MD. FACS, FACC, FCCP, Associate Professor of Surgery, Director Thoracic Surgical ICU and ECMO Program, Texas Heart Institute at CHI Baylor St. Lukes, explains the new 2026 expert consensus on heparin induced thrombocytopenia (HIT) released at the American Association for Thoracic Surgery (AATS) 2026 annual meeting. #AATS #AATS2026 #AATS26
AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.

doctor wrong patient wrong-site surgery medical error malpractice mistake
FDA announces more recalls due to risk of syringe breaking during treatment

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

How expert guidelines have influenced TAVR vs. SAVR decisions

As popular as TAVR is today, SAVR continues to play a significant role in the management of patients with valvular disease. 

Nicole B. Saphier, MD
Opposition forming against radiologist nominee for surgeon general

“Dr. Saphier would be a catastrophic mistake on messaging and communicating with MAHA at a time where the coalition is very fragile,” one opponent says. 

Siemens Healthineers
Siemens Healthineers shakes up leadership team, cuts profit outlook

The Erlangen, Germany-based device manufacturer announced its quarterly earnings results on May 7, which included a 6.5% year-over-year decline in revenue for its diagnostics segment. 

Thumbnail
PSMA PET imaging’s proliferation produces uptick in aggressive treatment for prostate cancer

First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer. 

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.
CMS unveils $50 GLP-1 prescriptions for Medicare patients

The agency said the new program, made possible by Medicare Part D, begins on July 1 and will extend until the end of 2027. For $50 a month, Medicare beneficiaries will be able to access popular weight loss drugs, in hopes they will improve overall health.

money cybersecurity ransomware health IT data breach hacker
Kettering Health hit with class-action lawsuit weeks after ransomware attack

Law firm Wright & Schulte said they filed a legal complaint on behalf of patients, pointing to the health system’s alleged lack of transparency and negligence in protecting data as the basis for the lawsuit.

Janet Wei, MD, Erika J. Glazer Chair in Women’s Cardiovascular Research, Education and Innovation at the Smidt Heart Institute at Cedars-Sinai Hospital, explains the key differences between men and women in cardiovascular disease presentations and disease progression. She said heart disease its the number one cause of death in women and the guidelines cannot be a one size fits all document lumping men and women together, they really need to separate out specific details for women.
Cardiology societies should develop separate guidelines for treating female heart patients

Janet Wei, MD, examined the key differences between men and women when it comes to cardiovascular disease. These differences, she said, highlight why female patients need their very own treatment guidelines.

money business cash flow dollar
Atraverse Medical raises $29M to support FDA-approved heart tech

The San Diego-based startup gained FDA approval for its Hotwire RF guidewire in 2024. The technology has already been used to perform hundreds of heart procedures.

Thumbnail
Bayer seeks FDA approval for gadoquatrane, its latest low-dose GBCA

The investigational agent uses 60% less gadolinium without sacrificing image quality, according to recent clinical trial findings.

Around the web

Health Exec
AI course-of-care notes help doctors, pose little risk of harm to patients

Agentic large-language models can draft hospital discharge summaries that are safe, useful and demonstrably effective at helping to curb physician burnout, according to research conducted at Stanford University.

Cardiovascular Business
AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.

Cardiovascular Business
FDA announces more recalls due to risk of syringe breaking during treatment

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

Design by Adaptive Theme